Unexplained weight loss (UWL), clinically defined as a loss of 5% or more of body weight within a six to twelve-month period, is a challenging diagnostic puzzle. It often indicates serious underlying pathology and necessitates a thorough and systematic approach for accurate diagnosis.
UWL can be attributed to a myriad of causes, most commonly malignancies, gastrointestinal disorders, endocrine diseases, and psychiatric illnesses. Understanding the pathophysiology of these conditions is crucial in formulating a comprehensive diagnostic plan.
A patient-centric, systematic approach is recommended for diagnosing UWL. A detailed history, physical examination, and basic laboratory tests form the cornerstone of this approach. Special attention should be given to age, associated symptoms, and risk factors. In older patients, malignancies and chronic diseases are more prevalent, while in younger patients, psychiatric disorders and malabsorption syndromes should be considered.
While routine imaging is not recommended, it may be warranted in certain cases. For instance, if the clinical history and physical examination suggest a specific organ involvement, targeted imaging can be beneficial. Similarly, in patients with significant weight loss and no clear diagnosis after initial evaluation, computed tomography (CT) of the chest, abdomen, and pelvis may be considered.
Follow-up is crucial in cases of UWL. If initial investigations are inconclusive, patients should be closely monitored for the emergence of new symptoms. This allows for timely intervention and improved patient outcomes.
Diagnosing UWL requires a comprehensive, systematic, and patient-centric approach. Understanding the etiology, adopting an appropriate diagnostic approach, recognizing the role of imaging, and emphasizing the importance of follow-up are all integral to successfully deciphering this enigma. By doing so, clinicians can ensure timely and appropriate management, ultimately improving patient outcomes.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation